MergeWorthRx Corp.

CIK:0001571088|SEC Filings

Organization, Plan of Business Operations and Going Concern (Details Textual) (USD $)	1 Months Ended		3 Months Ended		6 Months Ended	9 Months Ended
	Jul. 31, 2013	Jun. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2013	Sep. 30, 2014
Subsidiary, Sale of Stock [Line Items]
Percentage Of Public Offering		10.00%
Proceeds from Issuance of Private Placement							$ 63,452,400
Share Price			$ 8.36				$ 8.36
Fair Value Of Target Business To Be Acquired Minimum Percentage Of Trust Account Balance			80.00%		80.00%		80.00%
Minimum Acceptable Net Tangible Asset Value Of Company At Date Of Business Combination			5,000,001				5,000,001
Percentage Of Restricted Public Shares Available To Stockholder Acting In Concert Or As Group For Conversion			25.00%				25.00%
Common Stock Redemption Percentage							100.00%
Public Stockholders Pro Rata Interest Amount Per Share In Trust Account							$ 8.36
Proceeds from Issuance Initial Public Offering	52,800,000				7,920,000		698,892
Net Income (Loss) Attributable to Parent, Total			178,411	75,262		83,750	341,919
Working Capital (Deficit)			283,229				283,229
Restricted Cash and Cash Equivalents, Current			22,330				22,330
Retained Earnings (Accumulated Deficit), Total			537,683		195,764		537,683
Common Stock, Par or Stated Value Per Share			$ 0.0001		$ 0.0001		$ 0.0001
Held to Maturity Securities Debt Maturities Period							180 days
Board of Directors Chairman [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from Issuance of Private Placement					633,600
Underwritter [Member]
Subsidiary, Sale of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period					990,000
Underwriting Discounts And Commissions					7,642,800
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		6,000,000			6,600,000
Share Price					$ 8.00
Proceeds from Issuance Initial Public Offering							50,333,392
Common Stock, Par or Stated Value Per Share			$ 0.0001				$ 0.0001
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues					634,250
Proceeds from Issuance of Private Placement					5,074,000
Share Price			$ 8.00		$ 8.00		$ 8.00
Proceeds from Issuance Initial Public Offering					$ 5,074,000
Stock Issued During Period, Shares, Other					79,200
Sale of Stock, Price Per Share			$ 8.00				$ 8.00
Private Placement [Member] \| Board of Directors Chairman [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues					79,200
Anvil Merger Sub Inc [Member]
Subsidiary, Sale of Stock [Line Items]
Entity Incorporation, Date of Incorporation							Sep. 18, 2014

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
Consolidated Statements of Cash Flows (USD $)	Sep. 30, 2013	Sep. 30, 2014
Cash Flows from Operating Activities:
Net loss	$ (83,750)	$ (341,919)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest reinvested in Trust Account	(13,324)	(15,068)
Changes in operating assets and liabilities:
Security deposit	(5,152)	5,152
Prepaid expenses	(86,990)	20,944
Accrued expenses and accounts payable	38,982	119,514
Net cash used in operating activities	(150,234)	(211,377)
Cash Flows from Investing Activities:
Interest disbursed from Trust Account	0	14,547
Principal deposited in Trust Account	(63,452,400)	0
Net cash provided by (used in) investing activities	(63,452,400)	14,547
Cash Flows from Financing Activities:
Proceeds from public and private offering	66,452,600	0
Payment of underwriters' discount and offering expenses	(2,565,328)	0
Proceeds from notes payable to shareholders	170,000	0
Repayment of notes payable to shareholders	(170,000)	0
Net cash provided by financing activities	63,887,272	0
Net Change in Cash and Cash Equivalents	284,638	(196,830)
Cash and Cash Equivalents - Beginning	0	219,160
Cash and Cash Equivalents - Ending	284,638	22,330
Noncash Financing Activities:
Payment of operational costs by an officer pursuant to a related party advance	$ 0	$ 100,030

Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents	$ 22,330	$ 219,160
Prepaid expenses	27,271	48,215
Total Current Assets	49,601	267,375
Other Assets
Investments held in trust	63,452,938	63,452,417
Security deposits	0	5,152
Total Other Assets	63,452,938	63,457,569
Total Assets	63,502,539	63,724,944
Current Liabilities
Accrued expenses and accounts payable	52,920	33,436
Accrued offering costs	179,880	179,880
Related party advance	100,030	0
Total Liabilities	332,830	213,316
Commitments and Contingencies
Common stock subject to possible redemption, 6,958,099 and 6,998,998 shares at conversion value as of September 30, 2014 and December 31, 2013, respectively	58,169,708	58,511,627
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value; 5,000,000 authorized, none issued and outstanding	0	0
Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,242,851 and 3,201,952 shares issued and outstanding (excluding 6,958,099 and 6,998,998 shares subject to conversion) as of September 30, 2014 and December 31, 2013, respectively	324	320
Additional paid-in capital	5,537,360	5,195,445
Accumulated deficit	(537,683)	(195,764)
Total Stockholders' Equity	5,000,001	5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 63,502,539	$ 63,724,944